Nonlinear mixed effect modelling is a core component of many model-informed drug development (MIDD) approaches pursued by industry sponsors seeking to develop new drugs, vaccines ... Read more ➜
This is the third in a series of five blogs, assessing the Aridhia DRE, our enterprise Trusted Research Environment, against the SATRE specification. The first ... Read more ➜
This is the second in a series of five blogs, assessing the Aridhia DRE, our enterprise Trusted Research Environment, against the SATRE specification. The first ... Read more ➜
This is the first in a series of blogs exploring the emergence of open standards and specifications for Trusted Research Environments, with a particular emphasis ... Read more ➜
I was honored to be included at the Oncology Real-World Evidence (RWE) Workshop, hosted in Washington, D.C. last month by Friends of Cancer Research, Reagan-Udall ... Read more ➜
Rare diseases represent a highly heterogeneous group of disorders with high phenotypic and genotypic diversity within individual conditions. Due to the small numbers of people ... Read more ➜
AI and Healthcare Data In Amanda’s recent blog she discussed what she’s hearing in the marketplace with regards to the applications of AI in healthcare, particularly ... Read more ➜
Aridhia is proud to support the Royal Marsden Hospital (RMH) and the Institute for Cancer Research’s (ICR) progress in developing a system that not only ... Read more ➜
The pharmaceutical industry including small and large organizations and biotech as well as other stakeholders in the health arena are increasingly aware of the benefits ... Read more ➜
The medical imaging landscape has been rapidly evolving in recent years. Driven by advancements in technology and analysis methods, there’s growing demand to harness this ... Read more ➜